In vitro tube formation assays mimic blood vessel formation, but long turnaround times create drug testing bottlenecks. Download this technical note to explore how a qualitative, real-time, ...

The strategic scale-up enhances Sphere Bio’s ability to provide localised product support and increase adoption of its growing technology portfolio, including the recently launched Cyto-Mine® Chroma ...

The authors confirm that the absence of the asterisks does not negatively affect the understanding of the data or lead to any misinterpretation, as the statistical significance of the findings is ...

Sphere Bio has introduced the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, the first multiplexed assay designed for its next-generation Cyto-Mine® Chroma platform. This innovative solution ...

T-cell therapy capitalizes on the immune system’s capacity to recognize and kill tumor cells ... of a granzyme B assay suitable for studying cell-mediated cytotoxicity with Sphere Bio’s ...

Pharmacological inhibition of HPK1 enhances pulmonary and neurological functions following an AIS. This study aimed to investigate whether and how HPK1 is involved in neutrophil inflammatory responses ...

Cambridge, UK, 31 st March 2025: Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, announces the launch of the ...

Dr. Xin Liu, Senior Product Manager for Assays and Applications, Sphere Bio, commented: "Our new assay kit is a game-changer for single-cell workflows. By integrating viability assessment with ...